(The Atlantic) – Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

This insistence on the status quo has begun to seem a little strange. It’s long been known that prescribing dieting and exercise simply isn’t that effective as a treatment for obesity. People may slim down enough, at least initially, to prevent or help control type 2 diabetes, said Tom Wadden, an obesity researcher at the University of Pennsylvania who has been involved in clinical trials of both lifestyle modifications and GLP-1 drugs as treatments for obesity. But he told me that amount of weight loss will not reverse sleep apnea or prevent heart attacks or strokes.

For people with severe obesity today, even the modest benefits of dieting and exercise seem moot. Over the past few years, clinical trials of Ozempic and related drugs have shown that the “cornerstone” of treatment adds almost nothing to these medicines’ effects on people’s body weight. (Read More)